Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples